Date Filed | Type | Description |
06/16/2023 |
4
| Brege Laura (Director) has filed a Form 4 on Pacira BioSciences, Inc.
Txns:
| Granted 1,775 shares
@ $0 Granted 12,925 options to buy
@ $38.74, valued at
$500.7k
|
|
06/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/07/2023 |
4
| Brege Laura (Director) has filed a Form 4 on Pacira BioSciences, Inc.
Txns:
| Sold 600 shares
@ $38.74, valued at
$23.2k
|
|
04/05/2023 |
4
| Brege Laura (Director) has filed a Form 4 on Pacira BioSciences, Inc.
Txns:
| Sold 7,000 shares
@ $40.72, valued at
$285k
Exercised 7,000 options to buy
@ $29.9, valued at
$209.3k
|
|
04/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/08/2022 |
4
| Brege Laura (Director) has filed a Form 4 on Pacira BioSciences, Inc.
Txns:
| Granted 1,160 shares
@ $0 Granted 8,225 options to buy
@ $59.39, valued at
$488.5k
|
|
06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/11/2021 |
4
| Brege Laura (Director) has filed a Form 4 on Pacira BioSciences, Inc.
Txns:
| Granted 1,066 shares
@ $0 Granted 7,626 options to buy
@ $60.96, valued at
$464.9k
|
|
06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/25/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
11/17/2020 |
4
| Brege Laura (Director) has filed a Form 4 on Pacira BioSciences, Inc.
Txns:
| Sold 12,000 shares
@ $65.95, valued at
$791.4k
Exercised 12,000 options to buy
@ $13.98, valued at
$167.8k
|
|
07/02/2020 |
4
| Brege Laura (Director) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns:
| Disposed/sold 13,194 shares
@ $18, valued at
$237.5k
Disposed/sold 7,281 restricted stock units
@ $18, valued at
$131.1k
Disposed/sold 11,377 options to buy
@ $17.94, valued at
$204.1k
Disposed/sold 44,991 options to buy
@ $0 |
|
06/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/15/2020 |
4
| Brege Laura (Director) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns:
| Granted 7,281 shares
@ $0 Granted 11,377 options to buy
@ $17.94, valued at
$204.1k
|
|
06/15/2020 |
4
| Brege Laura (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns:
| Granted 14,167 options to buy
@ $16.71, valued at
$236.7k
|
|
06/11/2020 |
4
| Brege Laura (Director) has filed a Form 4 on Pacira BioSciences, Inc.
Txns:
| Granted 1,260 shares
@ $0 Granted 8,027 options to buy
@ $47.65, valued at
$382.5k
|
|
06/08/2020 |
4
| Brege Laura (Director) has filed a Form 4 on Pacira BioSciences, Inc.
Txns:
| Sold 2,100 shares
@ $48.7, valued at
$102.3k
|
|
01/08/2020 |
4
| Brege Laura (Director) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns:
| Sold 10,000 shares
@ $42.19, valued at
$421.9k
Exercised 10,000 options to buy
@ $1.75, valued at
$17.5k
|
|
09/12/2019 |
4
| Brege Laura (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns:
| Bought 10,000 shares
@ $11.22, valued at
$112.2k
|
|
07/18/2019 |
4
| Brege Laura (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns:
| Granted 17,000 options to buy
@ $15, valued at
$255k
|
|
07/17/2019 |
3
| Brege Laura (Director) has filed a Form 3 on Mirum Pharmaceuticals, Inc. |
06/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/17/2019 |
4
| Brege Laura (Director) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns:
| Granted 4,194 shares
@ $0 Granted 6,991 options to buy
@ $26.09, valued at
$182.4k
|
|
06/06/2019 |
4
| Brege Laura (Director) has filed a Form 4 on Pacira BioSciences, Inc.
Txns:
| Granted 4,134 shares
@ $0 Granted 8,437 options to buy
@ $43.54, valued at
$367.3k
|
|
05/31/2019 |
4
| Brege Laura (Director) has filed a Form 4 on DYNAVAX TECHNOLOGIES CORP
Txns:
| Granted 15,000 options to buy
@ $4.97, valued at
$74.6k
|
|
01/11/2019 |
4
| Brege Laura (Director) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns:
| Sold 10,000 shares
@ $20.0041, valued at
$200k
Exercised 10,000 options to buy
@ $2.16, valued at
$21.6k
|
|
07/30/2018 |
4
| Brege Laura (Director) has filed a Form 4 on ARATANA THERAPEUTICS, INC.
Txns:
| Granted 4,500 shares
@ $0 Granted 7,500 options to buy
@ $4.36, valued at
$32.7k
|
|
06/15/2018 |
4
| Brege Laura (Director) has filed a Form 4 on Pacira Pharmaceuticals, Inc.
Txns:
| Granted 782 shares
@ $0 Granted 4,693 options to buy
@ $38.35, valued at
$180k
|
|
06/08/2018 |
4
| Brege Laura (Director) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns:
| Granted 3,000 shares
@ $0 Granted 6,000 options to buy
@ $42.81, valued at
$256.9k
|
|
06/08/2018 |
4
| Brege Laura (Director) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns:
| Granted 15,000 options to buy
@ $17.52, valued at
$262.8k
|
|
|